Page last updated: 2024-10-22

amodiaquine and Congenital Zika Syndrome

amodiaquine has been researched along with Congenital Zika Syndrome in 2 studies

Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bernatchez, JA1
Tran, LT1
Li, J1
Luan, Y1
Siqueira-Neto, JL1
Li, R1
Zhou, T1
Tan, L1
Cederquist, GY1
Fan, Y1
Hartley, BJ1
Mukherjee, S1
Tomishima, M1
Brennand, KJ1
Zhang, Q1
Schwartz, RE1
Evans, T1
Studer, L1
Chen, S1

Reviews

1 review available for amodiaquine and Congenital Zika Syndrome

ArticleYear
Drugs for the Treatment of Zika Virus Infection.
    Journal of medicinal chemistry, 2020, 01-23, Volume: 63, Issue:2

    Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zik

2020

Other Studies

1 other study available for amodiaquine and Congenital Zika Syndrome

ArticleYear
High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain.
    Cell stem cell, 2017, 08-03, Volume: 21, Issue:2

    Topics: Adolescent; Amaryllidaceae Alkaloids; Amodiaquine; Animals; Antiviral Agents; Brain; Cell Line; Chil

2017